Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease - PubMed (original) (raw)
Affiliations
- PMID: 2806492
Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease
J Vestbo et al. Eur Respir J. 1989 Sep.
Abstract
The predictive value of cough, mucus hypersecretion, breathlessness, chronic bronchitis and forced expiratory volume in one second (FEV1) for hospitalization and medication were examined in a random population sample of 876 men, 46-69 yrs of age. All of the men were examined in 1974 with interview and lung function tests. Information on hospitalization in the period 1977-1986 was obtained from the Danish National Patient Register, and information on drug usage was obtained from 567 men in a questionnaire survey ultimo 1985. FEV1 was a strong predictor of both hospitalization and medication. Respiratory symptoms were good predictors of hospitalization due to either respiratory disease in general (odds ratios 2.56-3.29), or chronic obstructive pulmonary disease (COPD), (odds ratios 4.16-5.75). They contained predictive values in addition to that provided by FEV1. Respiratory symptoms were good predictors of medication for airway obstruction, relative risks 3.56-4.70, and/or airway disease in general, relative risks 2.67-4.69. After controlling for FEV1, cough was still significantly associated with treatment for airway disease in general and both cough, mucus hypersecretion and chronic bronchitis were significantly associated with treatment for airway obstruction. We conclude that apart from FEV1, respiratory symptoms are independent predictors of hospitalization and medication due to respiratory disease.
Similar articles
- Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
Vestbo J, Prescott E, Lange P. Vestbo J, et al. Am J Respir Crit Care Med. 1996 May;153(5):1530-5. doi: 10.1164/ajrccm.153.5.8630597. Am J Respir Crit Care Med. 1996. PMID: 8630597 - Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer.
Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Lange P, et al. Am Rev Respir Dis. 1990 Mar;141(3):613-7. doi: 10.1164/ajrccm/141.3.613. Am Rev Respir Dis. 1990. PMID: 2310094 - Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
Mohamed Hoesein FA, Zanen P, Lammers JW. Mohamed Hoesein FA, et al. Respir Med. 2011 Jun;105(6):907-15. doi: 10.1016/j.rmed.2011.01.008. Epub 2011 Feb 5. Respir Med. 2011. PMID: 21295958 Review. - Mucoactive drugs in the management of chronic obstructive pulmonary disease.
Del Donno M, Olivieri D. Del Donno M, et al. Monaldi Arch Chest Dis. 1998 Dec;53(6):714-9. Monaldi Arch Chest Dis. 1998. PMID: 10063352 Review.
Cited by
- Prediction of COPD by the single-breath nitrogen test and various respiratory symptoms.
Olofson J, Bake B, Bergman B, Vanfleteren LEGW, Svärdsudd K. Olofson J, et al. ERJ Open Res. 2021 Sep 27;7(3):00383-2021. doi: 10.1183/23120541.00383-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34589539 Free PMC article. - ACO (Asthma-COPD Overlap) Is Independent from COPD: The Case in Favour.
Calverley PMA, Walker PP. Calverley PMA, et al. Diagnostics (Basel). 2021 Jun 30;11(7):1189. doi: 10.3390/diagnostics11071189. Diagnostics (Basel). 2021. PMID: 34208874 Free PMC article. Review. - The Association with COPD Readmission Rate and Access to Medical Institutions in Elderly Patients.
Kim TW, Choi ES, Kim WJ, Jo HS. Kim TW, et al. Int J Chron Obstruct Pulmon Dis. 2021 Jun 3;16:1599-1606. doi: 10.2147/COPD.S302631. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34113092 Free PMC article. - Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease.
Jo YS, Rhee CK, Kim KJ, Yoo KH, Park YB. Jo YS, et al. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620961688. doi: 10.1177/1753466620961688. Ther Adv Respir Dis. 2020. PMID: 33070701 Free PMC article. - Associations between vitamin D, adiposity, and respiratory symptoms in chronic spinal cord injury.
Walia P, Goldstein RL, Teylan M, Lazzari AA, Hart JE, Tun CG, Garshick E. Walia P, et al. J Spinal Cord Med. 2018 Nov;41(6):667-675. doi: 10.1080/10790268.2017.1374020. Epub 2017 Oct 9. J Spinal Cord Med. 2018. PMID: 28992807 Free PMC article.